Hexoskin's CEO Pierre-Alexandre Fournier joined astronaut David Saint-Jacques and other panelists this week to discuss innovation in space medicine at the Virtual MedTech Conference.
After 20 years of continuous human presence on the International Space Station, countries from around the world are getting ready to send humans farther into our solar system, beyond Earth's orbit. Technologies required to support long-duration missions, such as to Mars and back to the moon, will be critical to the next 50 years of space exploration.
The Canadian Space Agency, numerous innovative Canadian medical technology companies and the National Research Council of Canada, are performing key research to develop and incorporate novel medical devices solutions for long-duration human spaceflight.
Cutting-edge microgravity research and space-relevant clinical expertise are critical to ensure an autonomous crew health care system. Canadian scientists, clinicians and specialists have developed and demonstrated new devices for remote clinical care including point of care diagnostics and real-time astronaut monitoring.
Among these innovations, Hexoskin has launched the wearable Astroskin Bio-Monitor system to the International Space Station in 2018 to monitor astronaut's vital signs. The system is used since for medical research in micro-gravity but also for research on Earth by a wide community of clinicians working in universities and research centers around the world.
The video of the MedTech Conference panel has been published and is available on the conference platform for attendees here: https://medtechvirtual2020.pathable.co/meetings/virtual/v98noBALBh3R4Xa5e